ClinicalTrials.gg
CompletedNCT03791411NarratUNUpdated Jan 2, 2019

Nursing Narratives, Reflective Practice and Professional Development (NarratUN)

An observational study in Narrative Medicine, sponsored by Clinica Universidad de Navarra, Universidad de Navarra. Completed at 1 site in Spain. Per ClinicalTrials.gov, last updated 2019-01-02.

Sponsored by Clinica Universidad de Navarra, Universidad de Navarra · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
69
Sex
All
01

Study summary

Background: In addition to foster reflective practice, clinical narratives may be used as a means to improve nurses' critical thinking and their acquisition of clinical competencies. However, few studies have studied their potential value to promote nursing professional development and there is no evidence that shows their value as a tool to improve nurses' competencies to provide a person-centred nursing care.

Purpose: To evaluate the preliminary efficacy of narratives for the development of three nursing professional competences -respect, intentional presence and knowing the person- paramount to provide person-centred care.

Method: A pilot quasi-experimental study. A total of 34 nurses enrolled in a global training course of a nursing specialization were recruited in September 2016. All the nurses received a multi-component intervention based on the Critical Reflexive Inquiry Model. The strategies of this program consisted in the writing of 3 narratives; 3 masterclass of 3, 2 and 3 hours respectively; a discussion group; and a face-to-face interview. The NarratUN Evaluation tool was used to assess outcomes. The primary outcome was the difference in the mean of respect, intentional presence and knowing the person pre and post intervention. Changes within nurses were analyzed using Wilcoxon signed Rank test.

02

Conditions studied

  • Narrative Medicine

Keywords

  • Clinical Narratives
  • Respect
  • Intentional presence
  • knowing the person
  • Professional development
03

In context

Lead sponsor

Clinica Universidad de Navarra, Universidad de Navarra is the lead sponsor of 160 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Nurses enrolled in a global training course of nursing specialization, for the 2016-17, 2017-18, and 2018-19 courses. All students in the specialized training programme will be included, regardless of age or previous experience.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being in a specialized training programme

Exclusion criteria

Exclusion Criteria:

  • Not being in a specialized training programme
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
69 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Respect. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of respect value (pre-post)

    Time frame: 9 month

  2. Intentional presence. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of intentional presence value (pre-post)

    Time frame: 9 month

  3. Knowing the person. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of knowing the person value (pre-post)

    Time frame: 9 month

Secondary outcomes

  1. Handling the narrative. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of Handling the narrative value (pre-post)

    Time frame: 9 month

  2. Respect. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of respect value along different times of the study

    Time frame: 2 month follow-up

  3. Intentional presence. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of intentional presence value along different times of the study

    Time frame: 2 month follow-up

  4. Knowing the person. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of knowing the person value along different times of the study

    Time frame: 2 month follow-up

  5. Handling the narrative. Measurement tool: NarratUN Evaluation Tool (NET)

    The difference in the mean of Handling the narrative value along different times of the study

    Time frame: 2 month follow-up

07

Study locations

1 site
  • Ana Choperena Armendáriz
    Pamplona, Navarre 31009, Spain
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2016 to primary completion in Jun 2017, 8 months.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 21, 2018
First posted
Jan 2, 2019
StartActual
Oct 1, 2016
Primary completionActual
Jun 30, 2017
CompletionActual
Jun 30, 2017
Last update
Jan 2, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03791411
Responsible party
Sponsor
First posted
Jan 2, 2019
Start date
Oct 1, 2016
Primary completion
Jun 30, 2017
Completion
Jun 30, 2017
Last update
Jan 2, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion